CASTLE BIOSCIENCES, INC. Deferred Offering Costs
CASTLE BIOSCIENCES, INC. (CSTL) had Deferred Offering Costs of $1.67 million as of 2019-06-30, per its 10-Q filed 2019-09-03.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredOfferingCosts · last filed 2020-03-10
- 2019-06-30: Deferred Offering Costs $1.67M.
- 2018-12-31: Deferred Offering Costs $91.00K; Deferred Offering Costs as first filed $91.31K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2019-06-30 | $1.67M 10-Q · filed 2019-09-03 | |
| 2018-12-31 | $91.00K 10-K · filed 2020-03-10 | $91.31K 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |